Acurx Pharmaceuticals (ACXP) Earnings
|
Expand Research on ACXP
| Next EPS Date | 8/17/26 | EPS Growth Rate | +69.8% |
|---|---|---|---|
| Average EPS % Beat Rate | -219.7% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | +2.4% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
8/17/26  |
Q226 | N/A | -$0.57 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 5/12/26 | Q126 | -$0.62 | $0.00 | -$0.62 | N/A | N/A | N/A |  | | Details | |
| 3/13/26 | Q425 | -$5.32 | $0.00 | -$5.32 | N/A | N/A | N/A | | | Details | |
| 11/18/25 |
Q325 | N/A | -$0.15 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 8/12/25 | Q225 | -$1.89 | -$0.18 | -$1.71 | N/A | N/A | N/A | | | Details | |
| 5/13/25 | Q125 | -$0.11 | -$0.38 | +$0.27 | N/A | N/A | N/A | | | Details | |
| 3/18/25 |
Q424 | N/A | -$0.18 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 11/13/24 | Q324 | -$0.17 | -$0.15 | -$0.02 | N/A | N/A | N/A | | | Details |
